Americans love working from home. Does it love them back? A controversial new study says remote work is taking a toll on ...
After a four-month investigation, Nature Medicine has decided to pull a viral study that linked early-day PD-1/chemo ...
Part C domestic enrollment is underway at three clinical sites in the U.S.CHICAGO, June 25, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc.
Postbiotics are gaining momentum. How can ingredient branding support the accessibility of postbiotics in F&B applications?
The class of drugs known as DNA Damage Response inhibitors, which work by blocking cancer cells’ ability to repair their own damaged DNA, is expanding rapidly beyond its original anchor, the PARP ...
Nothing about long Covid adds up. All of this is very strange. Stranger still are patients’ stories of astonishing recoveries from severe long Covid, achieved entirely outside mainstream medicine. The ...
IAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 June 23, 2026 12:30 PM EDTCompany ParticipantsShaun Bagai - ...
Discusses Updated Long-term Data From Phase 2 BESTOW Clinical Trial in Kidney Transplantation June 22, 2026 8:00 ...
Morning Overview on MSN
Ozempic-style drugs were linked to about 30% lower breast-cancer odds in a 111,000-woman study
Researchers at the University of Pennsylvania analyzed data from 111,646 women and found that those who used GLP-1 receptor ...
Phase I/II study can serve as the primary basis of a Biologics License Application for accelerated approval with FDA ~ ~ Company intends to submit the BLA in third quarter ...
Morning Overview on MSN
Doctors say a few routine blood tests can flag trouble years before symptoms appear
Millions of patients walk out of primary-care offices each year with lab results that read “normal” while early signs of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results